Publicaciones en colaboración con investigadores/as de McGill University Health Centre (15)

2022

  1. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 93, Núm. 2, pp. 158-168

  2. Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study

    Journal of neurology, neurosurgery, and psychiatry

  3. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Disease-related cortical thinning in presymptomatic granulin mutation carriers

    NeuroImage: Clinical, Vol. 29

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

2020

  1. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort

    Applied Neuropsychology:Adult, pp. 1-8

  2. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 12, pp. 1325-1328

  3. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 91, Núm. 9, pp. 975-984

  4. Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers

    Annals of Neurology, Vol. 88, Núm. 1, pp. 113-122

2019

  1. Education modulates brain maintenance in presymptomatic frontotemporal dementia

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 10, pp. 1124-1130

  2. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

    The Lancet Neurology, Vol. 18, Núm. 12, pp. 1103-1111

  3. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

    Antiviral Research, Vol. 170

  4. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

    NeuroImage: Clinical, Vol. 24